MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
Antibodies to human full-length myelin oligodendrocyte glycoprotein (MOG-IgG) as detected by new-generation cell-based assays have recently been described in patients presenting with acute demyelinating disease of the central nervous system, including patients previously diagnosed with multiple scle...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 March 2018
|
| In: |
Journal of neuroinflammation
Year: 2018, Jahrgang: 15 |
| ISSN: | 1742-2094 |
| DOI: | 10.1186/s12974-018-1108-6 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12974-018-1108-6 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12974-018-1108-6 
|
| Verfasserangaben: | S. Jarius, K. Ruprecht, J.P. Stellmann, A. Huss, I. Ayzenberg, A. Willing, C. Trebst, M. Pawlitzki, A. Abdelhak, T. Grüter, F. Leypoldt, J. Haas, I. Kleiter, H. Tumani, K. Fechner, M. Reindl, F. Paul and B. Wildemann |
Search Result 1
MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
BioMed Central 19 March 2018
Article (Journal)
Buch/Monographie
Online Resource